As promising biosimilar therapies to treat inflammatory conditions become available next year, Cigna Pharmacy, which manages pharmacy benefits for some Cigna clients, is announcing that it will add biosimilars as preferred products on its commercial formularies at the same position as Humira.

Cigna has found that the average annual price of therapy for specialty drugs is $38,000 per patient, which is 75 times higher than non-specialty prescription drugs.

Two years ago, Cigna Corporation created Evernorth – an organization dedicated to making health care better. Today, we’re celebrating our successes and looking forward to the future.

There have been many innovations in the last few years aimed at helping people manage their weight safely and effectively. Newer weight-loss regimens may include prescription weight-loss drugs, as well as tools and support for medication adherence and life-style changes.